Efficacy and Safety of Sanjie Analgesic Capsule in Patients with Endometriosis-Associated Pain: A Multicenter, 3:1 Randomized, Double-Blind, Placebo-Controlled Trial
Chinese Journal of Integrative Medicine · 2024
DOI: 10.1007/s11655-024-3756-y ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Chinese Journal of Integrative Medicine, 2024. Verfasst von Jin-Hua Leng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing, 100730, China. Hauptthemen laut MEDLINE: Endometriosis, Drugs, Chinese Herbal, Analgesics, Capsules. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To assess the efficacy and safety of Sanjie Analgesic Capsule (SAC) in Chinese patients with endometriosis-associated pain. METHODS: This was a multicenter, randomized, double-blind, placebo-controlled trial conducted at 15 centers between November 2013 and July 2017 in China. Eligible 323 patients with endometriosis were randomized at a 3:1 ratio to the SAC group (241 cases) and placebo group (82 cases) by stratified block randomization. Patients in the SAC or placebo groups were given SAC or placebo 1.6 g 3 times per day, orally, respectively since the first day of menstruation for 3 consecutive menstrual cycles. The primary endpoint was clinical response to dysmenorrhea evaluated using a 10-point Visual Analogue Scale at 3 and 6 months. The secondary endpoint was the pain score evaluated by VAS (chronic pelvic pain, defecation pain, and dyspareunia) at 3 and 6 months, and the pain recurrence rate at 6 months. Adverse events (AEs) were recorded during the study. RESULTS: A total of 241 women were included in the SAC group, and 82 were in the placebo group. Among these women, 217 (90.0%) and 71 (86.6%) completed the intervention, respectively. At 3 months, overall response rate (ORR) was significantly higher in women administered SAC (80.1%) compared with those who received a placebo (30.5%, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing, 100730, China.
- Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, 100006, China.
- Department of Gynecology, Chinese PLA General Hospital, Beijing, 100039, China.
- Department of Gynecology, Peking University First Hospital, Beijing, 100034, China.
- Department of Gynecology, Beijing Chao-yang Hospital, Beijing, 100020, China.
- Department of Gynecology, Womens Hospital School of Medicine Zhejiang University, Hangzhou, Zhejiang Province, 310006, China.
Zitieren
APA
Leng, J. H., Duan, H., Guan, Z., Zhou, Y. F., Qu, H., Xu, K. H., Zhang, S. F., Zhang, Q., Wang, X., Lin, K. Q., & Lang, J. H. (2024). Efficacy and Safety of Sanjie Analgesic Capsule in Patients with Endometriosis-Associated Pain: A Multicenter, 3:1 Randomized, Double-Blind, Placebo-Controlled Trial. Chinese Journal of Integrative Medicine. https://doi.org/10.1007/s11655-024-3756-y
Vancouver
Leng JH, Duan H, Guan Z, Zhou YF, Qu H, Xu KH, et al. Efficacy and Safety of Sanjie Analgesic Capsule in Patients with Endometriosis-Associated Pain: A Multicenter, 3:1 Randomized, Double-Blind, Placebo-Controlled Trial. Chinese Journal of Integrative Medicine. 2024. doi:10.1007/s11655-024-3756-y
BibTeX
@article{Leng2024,
author = {Leng, Jin-Hua and Duan, Hua and Guan, Zheng and Zhou, Ying-Fang and Qu, Hong and Xu, Kai-Hong and Zhang, Shao-Fen and Zhang, Qin and Wang, Xin and Lin, Kai-Qing and Lang, Jing-He},
title = {Efficacy and Safety of Sanjie Analgesic Capsule in Patients with Endometriosis-Associated Pain: A Multicenter, 3:1 Randomized, Double-Blind, Placebo-Controlled Trial},
journal = {Chinese Journal of Integrative Medicine},
year = {2024},
doi = {10.1007/s11655-024-3756-y}
}
EUVIMED